Thioredoxin: a key factor in cold tumor formation and a promising biomarker for immunotherapy resistance in NSCLC
Abstract Immune checkpoint blockade (ICB) therapy has shown promising clinical efficacy in cancer treatment, but only a subset of patients experience significant therapeutic responses. Tumor cells respond to internal and external stresses, such as hypoxia and nutrient deprivation, by activating the...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2025-05-01
|
| coleção: | Respiratory Research |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12931-025-03259-w |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|